Citigroup’s Can-Fite BioPharma CANF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-553
| Closed | -$899 | – | 4790 |
|
|
2024
Q4 | $899 | Hold |
553
| – | – | ﹤0.01% | 4732 |
|
|
2024
Q3 | $1.11K | Hold |
553
| – | – | ﹤0.01% | 4618 |
|
|
2024
Q2 | $1.43K | Hold |
553
| – | – | ﹤0.01% | 4581 |
|
|
2024
Q1 | $1.23K | Hold |
553
| – | – | ﹤0.01% | 4633 |
|
|
2023
Q4 | $1.22K | Hold |
553
| – | – | ﹤0.01% | 4653 |
|
|
2023
Q3 | $1.47K | Hold |
553
| – | – | ﹤0.01% | 4272 |
|
|
2023
Q2 | $1.7K | Hold |
553
| – | – | ﹤0.01% | 4558 |
|
|
2023
Q1 | $1.27K | Sell |
553
-1
| -0.2% | -$2 | ﹤0.01% | 4414 |
|
|
2022
Q4 | $3.39K | Hold |
554
| – | – | ﹤0.01% | 4364 |
|
|
2022
Q3 | $4K | Hold |
554
| – | – | ﹤0.01% | 4492 |
|
|
2022
Q2 | $5K | Hold |
554
| – | – | ﹤0.01% | 4830 |
|
|
2022
Q1 | $7K | Hold |
554
| – | – | ﹤0.01% | 4878 |
|
|
2021
Q4 | $7K | Hold |
554
| – | – | ﹤0.01% | 4837 |
|
|
2021
Q3 | $9K | Hold |
554
| – | – | ﹤0.01% | 4728 |
|
|
2021
Q2 | $13K | Hold |
554
| – | – | ﹤0.01% | 4849 |
|
|
2021
Q1 | $14K | Buy |
+554
| New | +$14K | ﹤0.01% | 4767 |
|
|
2016
Q2 | – | Sell |
-1
| Closed | – | – | 4969 |
|
|
2016
Q1 | $0 | Buy |
+1
| New | – | ﹤0.01% | 5347 |
|
|
2015
Q4 | – | Sell |
-26
| Closed | -$16K | – | 5410 |
|
|
2015
Q3 | $16K | Buy |
+26
| New | +$16K | ﹤0.01% | 4169 |
|
|
2015
Q2 | – | Sell |
-3
| Closed | -$1K | – | 5538 |
|
|
2015
Q1 | $1K | Hold |
3
| – | – | ﹤0.01% | 5312 |
|
|
2014
Q4 | $2K | Buy |
+3
| New | +$2K | ﹤0.01% | 5203 |
|
|
2014
Q2 | – | Sell |
-3
| Closed | -$2K | – | 5471 |
|
|
2014
Q1 | $2K | Buy |
+3
| New | +$2K | ﹤0.01% | 5219 |
|